Sarepta Therapeutics Inc (SRPT)
Operating profit margin
| Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating income (ttm) | US$ in thousands | -94,831 | -267,824 | -399,282 | -509,795 | -587,408 | -536,201 | -535,181 | -438,284 | -394,726 | -459,710 | -524,613 | -627,223 | -598,002 | -564,163 | -623,666 | -610,188 | -747,202 | -705,563 | -614,707 | -561,216 |
| Revenue (ttm) | US$ in thousands | 1,403,300 | 1,243,336 | 1,104,982 | 1,003,434 | 975,683 | 933,013 | 876,047 | 835,184 | 765,786 | 701,887 | 645,564 | 600,082 | 573,356 | 540,099 | 495,074 | 450,191 | 407,496 | 380,833 | 365,135 | 344,580 |
| Operating profit margin | -6.76% | -21.54% | -36.13% | -50.81% | -60.20% | -57.47% | -61.09% | -52.48% | -51.55% | -65.50% | -81.26% | -104.52% | -104.30% | -104.46% | -125.97% | -135.54% | -183.36% | -185.27% | -168.35% | -162.87% |
March 31, 2024 calculation
Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $-94,831K ÷ $1,403,300K
= -6.76%
The operating profit margin of Sarepta Therapeutics Inc has shown a fluctuating trend over the past few quarters. The margin has ranged from -6.76% to -185.27% during the period from December 2019 to March 2024.
It is important to note that negative values indicate that the company's operating expenses have exceeded its operating income. The trend indicates that the company has been struggling to generate sufficient operating profits to cover its operating costs consistently.
The significant declines in operating profit margin, especially in the range of -104% to -185%, raise concerns about the company's ability to efficiently manage its costs and generate profits from its core operations. This trend may signal operational inefficiencies, pricing pressures, or other challenges that could impact the company's overall financial health and sustainability.
Further analysis of the company's cost structures, revenue streams, and strategic initiatives would be essential to identify the root causes of the declining operating profit margins and to develop appropriate corrective actions to improve the company's profitability in the future.
Peer comparison
Mar 31, 2024